Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies

Home Browse Search

dilutants and masking agents. To ensure reliability and accuracy of the lab result prior to review by the MRO, an initial lab positive, adulterated, substituted or invalid test result will be followed by confirmation tests performed in accordance with 49 CFR 40 and DHHS regulations. The split sample method of collection is mandatory for DOT -regulated drug testing. Under this methodology, the employee must provide at least 45 milliliters (ml) of urine, which is then divided into primary (30 ml) and secondary (15 ml) specimen bottles by the collector. In the event that the primary specimen is verified by the MRO as positive, adulterated or substituted, the second bottle will be sent by the primary testing lab to a second (DOT -approved) lab at the employee's request, which may be verbal or in writing. c. medical review of lab results General: The Company's Medical Review Officer (MRO) will review all drug test results confirmed by the lab as positive, adulterated, substituted, or invalid. Prior to reporting such results to the Company, the employee will be given a reasonable opportunity (72 hours from the time of contact by the DER, if not contacted directly by the MRO) to discuss the lab results with the MRO and to present a legitimate medical explanation (if any) for the lab result. The MRO has the discretion to extend the verification process for up to five days, if the MRO determines that there is a reasonable basis to believe that the employee will be able to produce relevant evidence concerning a legitimate medical explanation within that time. In the case of a confirmed positive for Opioids, the MRO may also require the employee to present him/herself to be examined for clinical evidence of substance abuse. Refusal to comply is equivalent to expressly declining to discuss the test result. If neither the MRO nor the DER are able to contact an employee within 10 days of the MRO's receipt of a certified test result from the lab, the MRO will verify the test result as a positive or refusal to test, as applicable, without the employee's input. For a period of 60 days from the MRO's verified report to the DER, the MRO must allow the employee to present information documenting that serious illness, injury, or other circumstances unavoidably precluded contact with the MRO and/or DER; and may, on the basis of such information, reopen the verification, allowing the employee to present information concerning whether there is a legitimate medical explanation for the confirmed test result. Even if an employee presents a legitimate medical explanation and the employee's drug test is verified as negative, the MRO may be required to bring fitness -for -duty considerations to the attention of third parties. [See 40.327] Once notified of a required drug test, the employee must remain available for contact by the Company and the MRO and must make contact with the Company at least daily. Failure to maintain contact with the Company shall be cause for disciplinary action up to and including discharge, solely at the option of the Company. ii. Except for the use of methadone, THC (or Marijuana), and medications containing alcohol, nothing in this policy prohibits an employee's use of a medication legally prescribed (for an FDA -approved use) by a licensed physician who: (a) is familiar with the employee's medical history and specific safety - sensitive duties, and (b) has advised the employee that the prescribed medication will not adversely affect the employee's ability to perform his or her safety - sensitive duties (e.g., to drive a commercial motor vehicle). iii. Medications prescribed for someone other than the employee will not be considered lawfully used by the employee under any circumstances. iv. Medications containing alcohol will not be considered lawfully used by the employee while on duty or within 4 hours prior to going on duty. 2020 Drug Screens Plus_ All Rights Reserved_ (16) FMCSA 20200101 266